Viskase Companies, Inc. (ENZN) Financials

ENZN Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 47.0 million 44.5 million
June 30, 2023 46.7 million 402000
March 31, 2023 46.5 million 43.4 million
Dec. 31, 2022 47.6 million 1.7 million

ENZN Free Cash Flow and Stock based compensation

No data available :(

ENZN Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2023 321000
June 30, 2023 183000
March 31, 2023 197000
Dec. 31, 2022 333000

ENZN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 - - -
June 30, 2023 - - -
March 31, 2023 - - -
Dec. 31, 2022 - - -

ENZN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 74.2 million
June 30, 2023 74.2 million
March 31, 2023 74.2 million
Dec. 31, 2022 74.2 million

ENZN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - - 225000 -
June 30, 2023 - - 318000 -
March 31, 2023 - - 285000 -
Dec. 31, 2022 - - 237000 -

ENZN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - -
June 30, 2023 - -
March 31, 2023 - -
Dec. 31, 2022 26000 -

ENZN

Price: $4.25

52 week price:
0.02
8.55

Earnings Per Share: -0.05 USD

P/E Ratio: -1.21

Exchange: OQX

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 5587

Market Capitalization: 28.8 million

Links: